Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 05, 2020 at 08:14 pm
Share
Yung Zip Chemical Ind. Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 104.489 million compared to TWD 102.805 million a year ago. Operating income was TWD 13.818 million compared to TWD 6.900 million a year ago. Net income was TWD 17.338 million compared to TWD 7.065 million a year ago. Basic earnings per share was TWD 0.41 compared to TWD 0.17 a year ago.
YUNG ZIP CHEMICAL IND. CO., LTD. is a Taiwan-based company principally engaged in the manufacturing and trading of pharmaceutical ingredient products. Its diclofenac sodium (DCS) is used for the treatment of rheumatoid arthritis, bursitis and inflammation. The acyclovir (ACV) is used for the treatment of herpes virus infections. The miconazole nitrate (MCN) is used for the treatment of yeast infection. The sodium starch glycolate (SSG) is used as disintegrant in pharmaceutical preparation. The Clonidine hydrochloride (CLD) is used for the treatment of hypertension. The Company mainly distributes its products in domestic market and overseas markets, including the United States of America (the USA), Thailand, Indonesia and the Philippines.